XII Medical is a clinical-stage medical technology company developing innovative neuromodulation therapies for obstructive sleep apnea.
xiimedical.com
Amber Therapeutics is developing a fully implantable, closed-loop neuromodulation therapy designed to treat mixed urinary incontinence (MUI).
amber-tx.com
Apreo Health is a clinical stage company pioneering an endobronchial treatment for severe emphysema.
apreohealth.com
Capstan is pioneering a robotic assisted catheter platform and custom heart valves implants.
capstanmedical.com
Cellares is pioneering end-to-end automation and factory-in-a-box technology to manufacture cell therapies.
cellares.com
Dragon Vascular is developing next-gen neurovascular solutions.
dragonvascular.com
Endogenex develops Pulsed Electric Field–based device therapies for the treatment of gastrointestinal and metabolic diseases.
endogenex.com
Flywheel is an imaging data management and analysis platform for support, research, clinical trials, and AI model development at scale.
flywheel.io
Medcrypt helps medtech companies meet and exceed FDA’s cybersecurity requirements, getting devices approved faster.
medcrypt.co
Neocis has an FDA-cleared robotic surgical system for high precision dental implants.
neocis.com
Optellum is an FDA-cleared AI decision-support software for lung cancer diagnosis.
optellum.com
Surge is developing an intra-operative immunotherapy delivery platform.
surgetx.com
VAHATICOR is aiming to transform cardiac care for coronary microvascular dysfunction (CMD) with the A-FLUX Reducer System.
vahaticor.com
